MIT chemists designed a molecule that repairs DNA damage in living cells

Every cell in your body sustains thousands of DNA damage events every day — from UV radiation, reactive oxygen species, metabolic byproducts, and environmental toxins. Your cells have elaborate natural repair machinery to fix this damage, but these systems become less efficient with age and can be overwhelmed under stress. When DNA damage accumulates faster than it is repaired, the results range from premature ageing to cancer. MIT chemists have now designed a synthetic molecule — called OxiRepair-7 — that mimics and augments the cell's own repair machinery, demonstrating reversal of one of the most common and damaging DNA lesions.

Why DNA damage repair matters for ageing and cancer

8-oxoguanine — the lesion OxiRepair-7 targets — is formed when a guanine base in DNA is oxidised by reactive oxygen species. It is one of the most mutagenic lesions known: if not repaired before cell division, it causes a G→T transversion — exactly the kind of mutation found in lung cancer, colorectal cancer, and many other tumour types. The natural repair enzyme OGG1 handles this lesion efficiently in young, healthy cells, but its activity declines with age. A synthetic molecule that supplements this function could, in principle, reduce the mutation burden that accumulates over a lifetime.

The road to clinical use

The team is candid about the distance between these in vitro results and a clinically useful drug. The molecule will need to demonstrate efficacy in vivo — in whole organisms rather than cultured cells — and will require extensive safety profiling. There is also the question of delivery: while OxiRepair-7 enters cells without a carrier, getting it to specific tissues in a living body is a different challenge. The researchers envision initial applications in cancer prevention for high-risk individuals, or in combination with chemotherapy to protect healthy cells from collateral DNA damage.